Part 1: IDH1 & IDH2 Inhibitors In Newly Diagnosed AML


Alexandra S. Wolff, PharmD, BCOP, discusses use of IDH1 and IDH2 inhibitors in newly diagnosed AML patients and highlights recently released trial data.

Related Videos
MP Studio -
Image credit: David A Litman |
Credit: AkuAku -
Image credit: Halfpoint |
Credit: AkuAku -
Image Credit: © Mongta Studio -
Image credit: Halfpoint |
luchschenF -
© 2024 MJH Life Sciences

All rights reserved.